Overview

  • Product name
    Anti-Chymotrypsin antibody
    See all Chymotrypsin primary antibodies
  • Description
    Rabbit polyclonal to Chymotrypsin
  • Specificity
    ab30453 recognises Chymotrypsin.
  • Tested applications
    Suitable for: ELISAmore details
  • Species reactivity
    Reacts with: Human
  • Immunogen

    Full length native protein (purified): Human pancreatic chymotrypsin.

Properties

Applications

Our Abpromise guarantee covers the use of ab30453 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
ELISA Use at an assay dependent dilution.

Target

  • Function
    Has chymotrypsin-type protease activity and hypocalcemic activity.
  • Tissue specificity
    Pancreas.
  • Involvement in disease
    Variations in CTRC influence susceptibility to chronic pancreatitis [MIM:167800]. Chronic pancreatitis is a persistent inflammatory disorder characterized by permanent destruction of the pancreatic parenchyma.
  • Sequence similarities
    Belongs to the peptidase S1 family. Elastase subfamily.
    Contains 1 peptidase S1 domain.
  • Information by UniProt
  • Database links
  • Alternative names
    • Caldecrin antibody
    • Chymotrypsin C antibody
    • Chymotrypsin-C antibody
    • ChymotrypsinC antibody
    • CLCR antibody
    • Ctrc antibody
    • CTRC_HUMAN antibody
    • ELA 4 antibody
    • ELA4 antibody
    • Elastase 4 antibody
    • Elastase IV antibody
    • Elastase4 antibody
    • ElastaseIV antibody
    • OTTHUMP00000044526 antibody
    • Serum calcium decreasing factor antibody
    see all

References

ab30453 has not yet been referenced specifically in any publications.

Customer reviews and Q&As

There are currently no Customer reviews or Questions for ab30453.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

Sign up